227 A computational semi-mechanistic pharmacology model of ATG101, a PD-L1/4–1BB bispecific antibody for treatment of solid tumors and NHL

• David Flowers,
• Marc Presler,
• Kas Subramanian,
• Theresa Yuraszeck,
• Hui Yuwen,
• Bing Hou,
• Dirk Hoenemann

Affiliations

David Flowers

3 Department of Interventional Radiology, Queen Alexandra Hospital, Portsmouth, UK

Marc Presler

1Applied BioMath, LLC, Concord, MA, USA

Kas Subramanian

1Applied BioMath, LLC, Concord, MA, USA

Theresa Yuraszeck

1Applied BioMath, LLC, Concord, MA, USA

Hui Yuwen

2Shanghai Antengene Corporation Limited, Shanghai, China

Bing Hou

3Antengene Corporation Co., Ltd, Shanghai, China

Dirk Hoenemann

4Antengene Pty Ltd, Melbourne, Australia